NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.55M | -44.29M | -48.48M | -88.25M | -80.01M |
| Total Depreciation and Amortization | 1.37M | 1.32M | 1.28M | 1.25M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.55M | 20.72M | 20.87M | 60.66M | 53.44M |
| Change in Net Operating Assets | -15.00K | 1.37M | 5.46M | 4.80M | 4.29M |
| Cash from Operations | -19.65M | -20.88M | -20.87M | -21.54M | -21.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 35.00K | 35.00K | 35.00K | 35.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00K | -48.00K | -50.00K | -33.00K | -35.00K |
| Cash from Investing | -100.00K | -13.00K | -15.00K | 2.00K | 0.00 |
| Total Debt Issued | 17.78M | 17.37M | 12.57M | 22.62M | 22.38M |
| Total Debt Repaid | -4.01M | -3.01M | -2.43M | -300.00K | -254.00K |
| Issuance of Common Stock | 5.21M | 3.46M | 350.00K | 1.67M | 1.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 510.00K | 3.04M | 1.59M | -3.59M | -3.20M |
| Cash from Financing | 19.49M | 20.85M | 12.08M | 20.39M | 20.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.00K | -41.00K | -8.80M | -1.14M | -464.00K |